Looks like you’re on the UK site. Choose another location to see content specific to your location
Galderma’s Harmony Programme shown to help increase patient satisfaction
Galderma has highlighted the results of new market research that demonstrate the benefits of its Harmony Programme for aesthetic healthcare professionals.
The research results have shown how Harmony raises both treatment standards and value in aesthetic practices, while enhancing patient satisfaction, resulting in more returning patients and an increase in full facial treatments.
Harmony was designed in association with international experts and was launched in 2014, offering a novel stepwise patient assessment and management method that includes a suite of tools for assessment, facial analysis and treatment plan follow-up.
The new report showed how overall patient satisfaction levels increased from 65 percent to 85 percent after the implementation of the Harmony Programme, while enabling practitioners to increase retention from 53 percent to 73 percent.
With Harmony, 51 percent of patients now receive a combination of facial injectable treatments, compared to 34 percent without Harmony. Meanwhile, the number of patients requesting full facial treatments jumped from 63 percent to 82 percent.
Ophelie Massaroni, global Harmony Programme manager at Galderma, said: "The Harmony Programme facilitates the development of a cost-effective personalised treatment plan for each patient. This creates value for money, as a satisfied patient will be more likely to continue with other treatments."
With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard